Subcutaneous U2932 Human Lymphoma Cancer Xenograft Model
Cell information:
U2932 cells are derived from human diffuse large B lymphoma cell line cells and highly express BCL2, BCL6 and p53. Click for more information (
Model information:
Subcutaneously inoculated in NOD/SCID mice and matrigel is required for tumor formation. Usually grouping at about 28 days after inoculation, and treatment time window after grouping is about 23 days.

Integrate Drug Discovery Service
Copyright yourname allrights reserved All rights reserved:Suzhou Truway Biotechnology Inc.